Table 1.
Patient demographics, and disease and treatment history (patients' self-assessment)
| Disease and treatment history | Proportion of patients, % | ||
|---|---|---|---|
| total (n = 104) |
first-line treatment (n = 67) |
second-line treatment (n = 37) |
|
| Age, years | |||
| 50–59 | 52.9 | 53.7 | 51.4 |
| 60–69 | 32.7 | 31.3 | 35.1 |
| 70+ | 14.4 | 14.9 | 13.5 |
| Working | |||
| Yesa | 40.4 | 37.3 | 45.9 |
| Nob | 59.6 | 62.7 | 54.1 |
| Relationship status | |||
| Married/long-term relationship | 67.3 | 68.7 | 64.9 |
| Single | 29.8 | 29.9 | 29.7 |
| Other | 2.9 | 1.5 | 5.4 |
| Children | |||
| None | 31.7 | 26.9 | 40.5 |
| 1–2 | 59.6 | 62.7 | 54.1 |
| 3 or more | 8.7 | 10.4 | 5.4 |
| Classification | |||
| Relapse | 69.0 | 75.0 | 60.0 |
| De novo disease | 31.0 | 25.0 | 40.0 |
| Time of primary diagnosis | |||
| Up to 2 years ago | 12.5 | 16.4 | 5.4 |
| 3–5 years ago | 37.5 | 37.3 | 37.8 |
| 6–10 years ago | 29.8 | 31.3 | 27.0 |
| >10 years ago | 20.2 | 14.9 | 29.7 |
| Breast cancer stage at primary diagnosis | |||
| IVa | 26.9 | 19.4 | 40.5 |
| IIIb | 18.3 | 16.4 | 21.6 |
| I/II/III (relapsed patients only)c | 54.8 | 64.2 | 37.8 |
| Current breast cancer stage | |||
| IV | 88.5 | 86.6 | 91.9 |
| IIIb | 11.5 | 13.4 | 8.1 |
| Time of diagnosis of current stage | |||
| Up to 2 years agoc | 45.2 | 59.7 | 18.9 |
| 3–5 years ago | 46.2 | 31.3 | 73.0 |
| 6–10 years ago | 7.7 | 7.5 | 8.1 |
| >10 years ago | 1.0 | 1.5 | 0.0 |
| Start of current anticancer treatment | |||
| 1–12 months (1 year) ago | 43.0 | 33.0 | 62.0 |
| 13–24 months (2 years) ago | 27.0 | 27.0 | 27.0 |
| 25–60 months (3–5 years) ago | 22.0 | 31.0 | 3.0 |
| More than 60 months (>5 years) ago | 8.0 | 9.0 | 5.0 |
| Current anticancer drug treatment | |||
| Oral medication | 79.8 | 80.6 | 78.4 |
| Injections | 28.8 | 23.9 | 37.8 |
| Infusions | 15.4 | 14.9 | 16.2 |
| Breast cancer treatments received | |||
| BEFORE diagnosis of aBC | |||
| Breast surgery | 83.7 | 85.1 | 81.1 |
| Lymph node dissection | 79.8 | 79.1 | 81.1 |
| Radiation therapy | 75.0 | 74.6 | 75.7 |
| Chemotherapy | 38.5 | 37.3 | 40.5 |
| Hormone therapy | 15.4 | 17.9 | 10.8 |
| Other | 2.9 | 3.0 | 2.7 |
a
Includes “employed”, “self-employed” and “other”.
b
Includes “unemployed”, “retired”, “unfit for work” and “in education/vocational training”.
c
The difference between patients receiving first- or second-line therapy was significant (p < 0.05). aBC, advanced breast cancer (includes locally advanced and metastatic breast cancer).